Pathway Financial Advisers’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,701
Closed -$62.4K 480
2023
Q4
$62.4K Sell
12,701
-1,175
-8% -$5.75K 0.02% 212
2023
Q3
$75.6K Buy
+13,876
New +$111K 0.03% 205
2023
Q1
$119K Buy
14,527
+2,991
+26% +$33K 0.05% 180
2022
Q4
$129K Buy
+11,536
New +$134K 0.05% 178

Other funds holding MPT

Pathway Financial Advisers's MPT Position: Q1 2024 in Review

Pathway Financial Advisers sold out of Medical Properties Trust (MPT) in Q1 2024, closing a stake of 12,701 shares — an estimated $62.4K sold.

Pathway Financial Advisers first reported a position in MPT in Q4 2022 and held it in 4 quarters. The position peaked at $129K in Q4 2022. 510 funds tracked by Wall St. Rank hold MPT as of Q1 2024.

  • Pathway Financial Advisers reported no remaining Medical Properties Trust position as of Q1 2024 after selling out during the quarter.
  • Pathway Financial Advisers sold 12,701 Medical Properties Trust shares in Q1 2024, an estimated $62.4K.
  • Pathway Financial Advisers first reported a position in Medical Properties Trust in Q4 2022 and held it in 4 quarters.
  • Pathway Financial Advisers's Medical Properties Trust position peaked at $129K in Q4 2022.
  • 510 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2024.

Based on Pathway Financial Advisers's 13F filing for Q1 2024, filed 29 May 2024.